143 related articles for article (PubMed ID: 11581005)
1. Metabolic effects of dehydroepiandrosterone replacement therapy in postmenopausal women.
Lasco A; Frisina N; Morabito N; Gaudio A; Morini E; Trifiletti A; Basile G; Nicita-Mauro V; Cucinotta D
Eur J Endocrinol; 2001 Oct; 145(4):457-61. PubMed ID: 11581005
[TBL] [Abstract][Full Text] [Related]
2. The effect of dehydroepiandrosterone on insulin resistance in patients with impaired glucose tolerance.
Talaei A; Amini M; Siavash M; Zare M
Hormones (Athens); 2010; 9(4):326-31. PubMed ID: 21112864
[TBL] [Abstract][Full Text] [Related]
3. Replacement of dehydroepiandrosterone enhances T-lymphocyte insulin binding in postmenopausal women.
Casson PR; Faquin LC; Stentz FB; Straughn AB; Andersen RN; Abraham GE; Buster JE
Fertil Steril; 1995 May; 63(5):1027-31. PubMed ID: 7720912
[TBL] [Abstract][Full Text] [Related]
4. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
[TBL] [Abstract][Full Text] [Related]
5. Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women.
Diamond P; Cusan L; Gomez JL; Bélanger A; Labrie F
J Endocrinol; 1996 Sep; 150 Suppl():S43-50. PubMed ID: 8943786
[TBL] [Abstract][Full Text] [Related]
6. Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids.
Genazzani AD; Stomati M; Bernardi F; Pieri M; Rovati L; Genazzani AR
Fertil Steril; 2003 Dec; 80(6):1495-501. PubMed ID: 14667889
[TBL] [Abstract][Full Text] [Related]
7. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women.
Dhatariya K; Bigelow ML; Nair KS
Diabetes; 2005 Mar; 54(3):765-9. PubMed ID: 15734854
[TBL] [Abstract][Full Text] [Related]
8. Oral dehydroepiandrosterone supplementation modulates spontaneous and growth hormone-releasing hormone-induced growth hormone and insulin-like growth factor-1 secretion in early and late postmenopausal women.
Genazzani AD; Stomati M; Strucchi C; Puccetti S; Luisi S; Genazzani AR
Fertil Steril; 2001 Aug; 76(2):241-8. PubMed ID: 11476767
[TBL] [Abstract][Full Text] [Related]
9. The safety of 52 weeks of oral DHEA therapy for postmenopausal women.
Panjari M; Bell RJ; Jane F; Adams J; Morrow C; Davis SR
Maturitas; 2009 Jul; 63(3):240-5. PubMed ID: 19410392
[TBL] [Abstract][Full Text] [Related]
10. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
[TBL] [Abstract][Full Text] [Related]
11. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
[TBL] [Abstract][Full Text] [Related]
12. Lack of dehydroepiandrosterone effect on a combined endurance and resistance exercise program in postmenopausal women.
Igwebuike A; Irving BA; Bigelow ML; Short KR; McConnell JP; Nair KS
J Clin Endocrinol Metab; 2008 Feb; 93(2):534-8. PubMed ID: 18029465
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of oral dehydroepiandrosterone-sulphate on metabolic syndrome features in pre- and postmenopausal obese women.
Gómez-Santos C; Hernández-Morante JJ; Tébar FJ; Granero E; Garaulet M
Clin Endocrinol (Oxf); 2012 Oct; 77(4):548-54. PubMed ID: 22136516
[TBL] [Abstract][Full Text] [Related]
14. Dehydroepiandrosterone supplementation is not beneficial in the late postmenopausal period in diet-induced obese rats.
Teixeira CJ; Ribeiro LM; Veras K; da Cunha Araujo LC; Curi R; de Oliveira Carvalho CR
Life Sci; 2018 Jun; 202():110-116. PubMed ID: 29601891
[TBL] [Abstract][Full Text] [Related]
15. Effects of dehydroepiandrosterone (DHEA) supplementation on hormonal, metabolic and behavioral status in patients with hypoadrenalism.
Libè R; Barbetta L; Dall'Asta C; Salvaggio F; Gala C; Beck-Peccoz P; Ambrosi B
J Endocrinol Invest; 2004 Sep; 27(8):736-41. PubMed ID: 15636426
[TBL] [Abstract][Full Text] [Related]
16. Effects of DHEA replacement on bone mineral density and body composition in elderly women and men.
Villareal DT; Holloszy JO; Kohrt WM
Clin Endocrinol (Oxf); 2000 Nov; 53(5):561-8. PubMed ID: 11106916
[TBL] [Abstract][Full Text] [Related]
17. Very short term dehydroepiandrosterone treatment in female adrenal failure: impact on carbohydrate, lipid and protein metabolism.
Christiansen JJ; Gravholt CH; Fisker S; Møller N; Andersen M; Svenstrup B; Bennett P; Ivarsen P; Christiansen JS; Jørgensen JO
Eur J Endocrinol; 2005 Jan; 152(1):77-85. PubMed ID: 15762190
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone in relation to adiposity, glucose tolerance and lipid spectra in Czech non-diabetic population.
Bendlová B; Vrbíková J; Hill M; Vaňková M; Lukášová P; Včelák J; Vejražková D; Dvořáková K; Hampl R; Vondra K; Stárka L
Physiol Res; 2008; 57 Suppl 1():S67-S76. PubMed ID: 18271690
[TBL] [Abstract][Full Text] [Related]
19. [Positive effects of DHEA therapy on insulin resistance and lipids in men with angiographically verified coronary heart disease--preliminary study].
Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):904-10. PubMed ID: 16821209
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone replacement in healthy men with age-related decline of DHEA-S: effects on fat distribution, insulin sensitivity and lipid metabolism.
Jedrzejuk D; Medras M; Milewicz A; Demissie M
Aging Male; 2003 Sep; 6(3):151-6. PubMed ID: 14628495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
